Sodium butyrate and its synthetic amide derivative modulate nociceptive behaviors in mice

Pharmacological Research

Volumn 103, Issue , 2016, Pages 279-291

  Russo, Roberto ^a   De Caro, Carmen ^a   Avagliano, Carmen ^a   Cristiano, Claudia ^a   La Rana, Giovanna ^a   Mattace Raso, Giuseppina ^a   Berni Canani, Roberto ^a   Meli, Rosaria ^a   Calignano, Antonio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

ATP dependent K+ channel; Chronic constriction injury (CCI); Formalin test; Inflammation; Nociception; Peroxisome proliferator activated receptora; Sodium butyrate; Visceral pain

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; BUTYRIC ACID; BUTYRIC ACID DERIVATIVE; CYCLOOXYGENASE 2; GLIBENCLAMIDE; I KAPPA B ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; KAOLIN; KETOROLAC; MAGNESIUM SULFATE; N (1 CARBAMOYL 2 PHENYL ETHYL)BUTYRAMIDE; PALMIDROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POTASSIUM CHANNEL; PROTEIN C FOS; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 2-CHLORO-5-NITROBENZANILIDE; ACETIC ACID; AMIDE; ANALGESIC AGENT; ANILIDE; FORMALDEHYDE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC CONSTRICTION INJURY; CHRONIC PAIN; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG MECHANISM; MALE; MECHANICAL HYPERALGESIA; MOUSE; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPEATED DRUG DOSE; THERMAL HYPERALGESIA; VISCERAL PAIN; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; GENETICS; HEAT; HYPERALGESIA; INJURIES; KNOCKOUT MOUSE; METABOLISM; PAIN; PHYSICAL STIMULATION; SCIATIC NERVE; SPINAL CORD;

ACETIC ACID; AMIDES; ANALGESICS; ANILIDES; ANIMALS; BUTYRIC ACID; FORMALDEHYDE; HOT TEMPERATURE; HYPERALGESIA; KAOLIN; MAGNESIUM SULFATE; MALE; MICE; MICE, KNOCKOUT; PAIN; PHYSICAL STIMULATION; PPAR ALPHA; PPAR GAMMA; SCIATIC NERVE; SPINAL CORD;

EID: 84950302845     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2015.11.026     Document Type: Article

References (48)

1. D.L. Topping, and P.M. Clifton Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides Physiol. Rev. 81 2001 1031 1064
2. H.M. Hamer, D. Jonkers, K. Venema, S. Vanhoutvin, F.J. Troost, and R.J. Brummer The role of butyrate on colonic function Aliment. Pharmacol. Ther. 27 2008 104 119
3. R.B. Canani, M.D. Costanzo, L. Leone, M. Pedata, R. Meli, and A. Calignano Potential beneficial effects of butyrate in intestinal and extraintestinal diseases World J. Gastroenterol. 17 2011 1519 1528
4. P. Guilloteau, L. Martin, V. Eeckhaut, R. Ducatelle, R. Zabielski, and F. Van Immerseel From the gut to the peripheral tissues: the multiple effects of butyrate Nutr. Res. Rev. 23 2010 366 384
5. J.R. Davie Inhibition of histone deacetylase activity by butyrate activity J.Nutr. 133 2003 2485 2493
6. H. Luhrs, T. Gerke, J.G. Muller, R. Melcher, J. Schauber, F. Boxberge, W. Scheppach, and T. Menzel Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis Scand. J. Gastroenterol. 37 2002 458 466
7. A.J. Brown, S.M. Goldsworthy, A.A. Barnes, M.M. Eilert, L. Tcheang, D. Daniels, A.I. Muir, M.J. Wigglesworth, I. Kinghorn, N.J. Fraser, N.B. Pike, J.C. Strum, K.M. Steplewski, P.R. Murdock, J.C. Holder, F.H. Marshall, P.G. Szekeres, S. Wilson, D.M. Ignar, S.M. Foord, A. Wise, and S.J. Dowell The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids J. Biol. Chem. 278 2003 11312 11319
8. S. Alex, K. Lange, T. Amolo, J.S. Grinstead, A.K. Haakonsson, E. Szalowska, A. Koppen, K. Mudde, D. Haenen, S. Al-Lahham, H. Roelofsen, R. Houtman, B. van der Burg, S. Mandrup, A.M. Bonvin, E. Kalkhoven, M. Müller, G.J. Hooiveld, and S. Kersten Short-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor Mol. Cell. Biol. 33 2013 1303 1316
9. J. LoVerme, R. Russo, G. La Rana, J. Fu, J. Farthing, G. Mattace-Raso, R. Meli, A. Hohmann, A. Calignano, and D. Piomelli Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha J. Pharmacol. Exp. Ther. 319 2006 1051 1061
10. P. Vernia, A. Marcheggiano, R. Caprilli, G. Frieri, G. Corrao, D. Valpiani, M.C. Di Paolo, P. Paoluzi, and A. Torsoli Short-chain fatty acid topical treatment in distal ulcerative colitis Aliment. Pharmacol. Ther. 9 1995 309 313
11. A.H. Steinhart, A. Brzezinski, and J.P. Baker Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas Am. J. Gastroenterol. 89 1994 179 183
12. J. Patz, W.Z. Jacobsohn, S. Gottschalk-Sabag, S. Zeides, and D.Z. Braverman Treatment of refractory distal ulcerative colitis with short chain fatty acid enemas Am. J. Gastroenterol. 91 1996 731 734
13. A. Pinto, P. Fidalgo, M. Cravo, J. Midoes, P. Chaves, J. Rosa, M. dos Anjos Brito, and C.N. Leitao Short chain fatty acids are effective in short-term treatment of chronic radiation proctitis: randomized double-blind, controlled trial Dis. Colon Rectum 42 1999 788 796
14. S.A. Vanhoutvin, F.J. Troost, T.O. Kilkens, P.J. Lindsey, H.M. Hamer, D.M. Jonkers, K. Venema, and R.J. Brummer The effects of butyrate enemas on visceral perception in healthy volunteers Neurogastroenterol. Motil. 21 2009 952 976
15. A.L. Tarrerias, M. Millecamps, A. Alloui, C. Beaughard, J.L. Kemeny, S. Bourdu, G. Bommelaer, A. Eschalier, M. Dapoigny, and D. Ardid Short-chain fatty acid enemas fail to decrease colonic hypersensitivity and inflammation in TNBS induced colonic inflammation in rats Pain 100 2002 91 97
16. S. Bourdu, M. Dapoigny, E. Chapuy, F. Artigue, M.P. Vasson, P. Dechelotte, G. Bommelaer, A. Eschalier, and D. Ardid Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats Gastroenterology 128 2005 1996 2008
17. A. Kukkar, N. Singh, and A.S. Jaggi Attenuation of neuropathic pain by sodium butyrate in an experimental model of chronic constriction injury in rats J. Formos. Med. Assoc. 113 2014 921 928
18. T. Banasiewicz, L. Krokowicz, Z. Stojcev, B.F. Kaczmarek, E. Kaczmarek, J. Maik, R. Marciniak, P. Krokowicz, J. Walkowiak, and M. Drews Microencapsulated sodium butyrate reduces the frequency of abdominal pain in patients with irritable bowel syndrome Colorectal Dis. 15 2013 204 209
19. G. Mattace Raso, R. Simeoli, R. Russo, A. Iacono, A. Santoro, O. Paciello, M.C. Ferrante, R.B. Canani, A. Calignano, and R. Meli Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet PLoS One 8 2013 e68626 10.1371/journal.pone.0068626
20. A. Calignano, G. La Rana, and D. Piomelli Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide Eur. J. Pharmacol. 419 2001 191 198
21. O. Sasso, R. Russo, S. Vitiello, G.M. Raso, G. D'Agostino, A. Iacono, G.L. Rana, M. Vallée, S. Cuzzocrea, P.V. Piazza, R. Meli, and A. Calignano Implication of allopregnanolone in the antinociceptive effect of N-palmitoylethanolamide in or persistent pain Pain 153 2012 33 34
22. J.H. Cumming, and W.J. Branch Fermentation and the production of short chain fatty acids in the human large intestine G.B. Vahouny, D. Kritchevsky, Dietary Fiber: Basic and Clinical Aspect 1986 Plenum Press New York 131 152
23. J.M. Wong, R. de Souza, C.W. Kendall, A. Emam, and D.J. Jenkins Colonic health: fermentation and short chain fatty acids J. Clin. Gastroenterol. 40 2006 235 243
24. K.P. Scott, S.W. Gratz, P.O. Sheridan, H.J. Flint, and S.H. Duncan The influence of diet on the gut microbiota Pharmacol. Res. 69 2013 52 60
25. A. Andoh, T. Bamba, and M. Sasaki Physiological and anti-inflammatory roles of dietary fiber and butyrate in intestinal functions J. Parenter. Enteral. Nutr. 23 1999 70 73
26. J.D. Butzner, R. Parmar, C.J. Bell, and V. Dalal Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat Gut 38 1996 568 573
27. J.P. Segain, D. Raingeard de la Bletiere, A. Bourreille, V. Leray, N. Gervois, C. Rosales, L. Ferrier, C. Bonnet, H.M. Blottière, and J.P. Galmiche Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease Gut 47 2000 397 403
28. -1 expression in cultured endothelial cells: the role of NF-kappaB and PPAR-alpha J. Nutr. Biochem. 15 2004 220 228
29. M. Kinoshita, Y. Suzuki, and Y. Saito Butyrate reduces colonic paracellular permeability by enhancing PPARgamma activation Biochem. Biophys. Res. Commun. 293 2002 827 831
30. M. Schwab, V. Reynders, S. Loitsch, D. Steinhilber, J. Stein, and O. Schröder Involvement of different nuclear hormone receptors in butyrate-mediated inhibition of inducible NF-kappaB signaling Mol. Immunol. 44 2007 3625 3632
31. A. Wachtershauser, S.M. Loitsch, and J. Stein PPAR-gamma is selectively upregulated in Caco-2 cells by butyrate Biochem. Biophys. Res. Commun. 272 2000 380 385
32. L. Di Cesare Mannelli, G. D'Agostino, A. Pacini, R. Russo, M. Zanardelli, C. Ghelardini, and A. Calignano Palmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-alpha-mediated mechanism Mediators Inflamm. 2013 2013 328797 10.1155/2013/328797
33. L. Dubuquoy, C. Rousseaux, X. Thuru, L. Peyrin-Biroulet, O. Romano, P. Chavatte, M. Chamaillard, and P. Desreumaux PPAR-gamma as a new therapeutic target in inflammatory bowel diseases Gut 55 2006 1341 1349
34. S. Krishnan, B.S. Ramakrishna, and H.J. Binder Stimulation of sodium chloride absorption from secreting rat colon by short-chain fatty acids Dig. Dis. Sci. 44 1999 1924 1930
35. M. Diener, and E. Scharrer Effects of short-chain fatty acids on cell volume regulation and chloride transport in the rat distal colon Comp. Biochem. Physiol. A. Physiol. 118 1997 375 379
36. M. Diener, and E. Scharrer The effect of short-chain fatty acids on Cl- and K+ conductance in rat colonic crypts Pflugers Arch. 426 1994 472 480
37. R. Berni Canani, G. Terrin, G. Cardillo, R. Tomaiuolo, and G. Castaldo Congenital diarrheal disorders: improved understanding of gene defects is leading to advances in intestinal physiology and clinical management J. Pediatr. Gastroenterol. Nutr. 50 2010 360 363
38. R. Berni Canani, G. Terrin, P. Cirillo, G. Castaldo, F. Salvatore, G. Cardillo, A. Coruzzo, and R. Troncone Butyrate as an effective treatment of congenital chloride diarrhea Gastroenterology 127 2004 630 634
39. M.A. Cuff, D.W. Lambert, and S.P. Shirazi-Beechey Substrate-induced regulation of the human colonic monocarboxylate transporter, MCT1 J. Physiol. 539 2002 361 371
40. A. Borthakur, S. Saksena, R.K. Gill, W.A. Alrefai, K. Ramaswamy, and P.K. Dudeja Regulation of monocarboxylate transporter 1 (MCT1) promoter by butyrate in human intestinal epithelial cells: involvement of NF-kappaB pathway J. Cell. Biochem. 103 2008 1452 1463
41. A. Borthakur, S. Priyamvada, A. Kumar, A.A. Natarajan, R.K. Gill, W.A. Alrefai, and P.K. Dudeja A novel nutrient sensing mechanism underlies substrate-induced regulation of monocarboxylate transporter-1 Am. J. Physiol. Gastrointest. Liver Physiol. 303 2012 1126 1133
42. A. Curcio, O. Sasso, D. Melisi, M. Nieddu, G. La Rana, R. Russo, E. Gavini, G. Boatto, E. Abignente, A. Calignano, and M.G. Rimoli Galactosyl prodrug of ketorolac: synthesis, stability, and pharmacological and pharmacokinetic evaluations J. Med. Chem. 52 2009 3794 3800
43. G. Mattace Raso, R. Russo, A. Calignano, and R. Meli Palmitoylethanolamide in CNS health and disease Pharmacol. Res. 86 2014 32 41
44. Y. Yamazaki, T. Maeda, G. Someya, and S. Wakisaka Temporal and spatial distribution of Fos protein in the lumbar spinal dorsal horn neurons in the rat with chronic constriction injury to the sciatic nerve Brain Res. 914 2001 106 114
45. L.S. Ro, H.Y. Li, K.F. Huang, and S.T. Chen Territorial and extra-territorial distribution of Fos protein in the lumbar spinal dorsal horn neurons in rats with chronic constriction nerve injuries Brain Res. 1004 2004 177 187
46. R. Berni Canani, M. Di Costanzo, and L. Leone The epigenetic effects of butyrate: potential therapeutic implications for clinical practice Clin. Epigenetics 4 2012 4
47. G. Bai, D. Wei, S. Zou, K. Ren, and R. Dubner Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia Mol. Pain 6 2010 51
48. S. Chiechio, M. Zammataro, ME, C.L. Morales, F. Busceti, R.W.G. Drago, A.C. ereau, F.N. opani, and icoletti Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain Mol. Pharmacol. 75 2009 1014 1020